Current Research into Cures for Type-1 Diabetes

Beta Cells Which Hide From The Immune System This has not progressed to clinical trials, but it is a new approach.  There is a lot of ongoin...

This blog posting is a summary of four small updates.  Unfortunately, they include research delay, two unsuccessful trials, and one trial un...

Ustekinumab was approved in the US in 2009 for treating psoriasis, which is an autoimmune disease (where the immune system self attacks ski...

Ustekinumab Is Fully Enrolled Ustekinumab, an immune modulating drug, started a Phase-II? trial in July 2014.  I previously blogged about...

Exsulin is a drug designed to trigger beta cell growth and Ustekinumab is designed to modulate the immune system.  These researchers are te...

Secukinumab and Ustekinumab have a lot in common, including both starting phase-II trials in the last few months, so I'm covering the...